Figure 9 : IYIY-I2-BODIPY treated mice have high CD4 + and CD8 + effector T cells in TDLN and spleen at 20 days post-PDT.

From: Tropomyosin Receptor Kinase C Targeted Delivery of a Peptidomimetic Ligand-Photosensitizer Conjugate Induces Antitumor Immune Responses Following Photodynamic Therapy

Figure 9

PDT was conducted at 100 J/cm2 based on four groups as indicated above. At 20 days post-PDT, mice were sacrificed for quantification of (a) CD4+ and (b) CD8+ effector T cells in TDLN and spleen that expressed CD44 surface antigen using flow cytometry. Data represent mean ± SEM of three mice for each group. *p < 0.005; **p < 0.005 vs three control groups using one-way ANOVA (Dunnett’s test).